Bel-2 as a prognostic factor of breast cancers
Watanabe, K.; Kawabata, K.; Ozaki, S.; Fujita, H.; Kojima, Y.; Tsuda, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 423-428
2000
ISSN/ISBN: 0047-1852 PMID: 11026028 Document Number: 523755
Document emailed within 1 workday
Related Documents
1990: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group Lancet 335(8705): 1565-1568Ohta, T.; Fukuda, M. 2000: Cell cycle regulators as prognostic factors of breast cancers Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 448-453
Feng, Y.-M.; Li, X.-Q.; Sun, B.-C.; Gao, X.-C.; Gu, L.; Niu, Y.; Hao, X.-S. 2006: Prognostic molecular classification of breast cancers based on gene expression profiling Zhonghua Zhong Liu Za Zhi 28(12): 900-906
Watson, A.P.; Egland, K.A. 2010: Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers South Dakota Medicine: the Journal of the South Dakota State Medical Association 63(7): 247-253
Shackney, S.E.; Pollice, A.A.; Smith, C.A.; Alston, L.; Singh, S.G.; Janocko, L.E.; Brown, K.A.; Petruolo, S.; Groft, D.W.; Yakulis, R.; Hartsock, R.J. 1996: The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications Cancer Journal from Scientific American 2(2): 106-113
Foekens, J.A.; Portengen, H.; van Putten, W.L.; Trapman, A.M.; Reubi, J.C.; Alexieva-Figusch, J.; Klijn, J.G. 1989: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer Cancer Research 49(24 Part 1): 7002-7009
Haase, W. 1995: Tissue CEA as a prognostic factor in patients with breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(2): 117-118
Eskelinen, M.; Lipponen, P.; Syrjänen, K. 1991: TAG 12 expression as a prognostic factor in female breast cancer Anticancer Research 11(5): 1683-1686
Utada, Y.; Emi, M.; Haga, S.; Kajiwara, T. 2000: Allelic loss as prognostic factor in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 473-477
Jansen, R.L.; Joosten-Achjanie, S.R.; Volovics, A.; Arends, J.W.; Hupperets, P.S.; Hillen, H.F.; Schouten, H.C. 1998: Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer Anticancer Research 18(6a): 4455-4462
Savino, A.; Koss, L.G. 1971: The evaluation of sex chromatin as a prognostic factor in carcinoma of the breast. A preliminary report Acta Cytologica 15(4): 372-374
Bonneterre, J.; Peyrat, J.P.; Beuscart, R.; Demaille, A. 1990: Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer Cancer Research 50(21): 6931-6935
Jansen, R.L.; Hupperets, P.S.; Arends, J.W.; Joosten-Achjanie, S.R.; Volovics, A.; Hillen, H.F.; Schouten, H.C. 1998: pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer Anticancer Research 18(1b): 577-582
Miyauchi, M. 1991: Objective evaluation of nuclear grade in preoperative aspiration materials from breast cancers--special reference to the relationship of coefficiency variant of nuclear area with pathological prognostic features Nihon Geka Gakkai Zasshi 92(11): 1642-1649
Sheen-Chen, S.-M.; Chou, F.-F.; Hsu, W.; Huang, C.-C.; Eng, H.-L.; Tang, R.-P. 2007: Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray Anticancer Research 27(5b): 3541-3544
Yokoe, T.; Ishida, T.; Iino, U.; Kawai, T.; Izuo, M. 1984: Clinicopathological study of breast cancers associated with other primary cancers Gan no Rinsho. Japan Journal of Cancer Clinics 30(15): 1883-1891
Ogawa, Y.; Chung, Y.S.; Nakata, B.; Takatsuka, S.; Maeda, K.; Sawada, T.; Kato, Y.; Yoshikawa, K.; Sowa, M. 1995: Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage i breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 1): 66-70
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Namwongprom, S.; Boonyaprapa, S.; Ekmahachai, M.; Vilasdechanon, N.; Somwangprasert, A.; Sumitsawan, S.; Taya, P. 2005: Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes Singapore Medical Journal 46(12): 688-692